Mesothelioma market | Size, Share, Growth

Mesothelioma market Research Report - Size, Share, Growth, and Trend Analysis | Forecast (2025 - 2030)

Published: 2025 - March

Report Code: VMR-18291

Region: Global

Request Sample

Customization

Ask an Expert

Enquire Enquire Before Buying

Mesothelioma market (2025-2030)

The Mesothelioma market is focused on the diagnosis, treatment, and management of mesothelioma, a rare and aggressive cancer primarily caused by asbestos exposure. The market encompasses various types of mesothelioma, including pleural, peritoneal, and pericardial, each requiring specific therapeutic approaches. The market is driven by a need for novel, effective treatments due to the high mortality rate and the limited options currently available. As new research and drug development continue, there are increasing opportunities for both innovation and market growth.

Disruptive Impact and Opportunities:

The market presents several disruptive opportunities, driven by the demand for new therapies that address the complex nature of mesothelioma. Emerging drugs, like MesoPher and Durvalumab, are opening new avenues for treatment, focusing on immunotherapy and targeted therapies. These drugs are expected to revolutionize mesothelioma treatment with new, easy-to-administer options that offer better safety profiles and larger efficacy in treating different subtypes of the disease. These advancements are likely to create new market leaders, as the demand for effective, safe, and affordable treatments is on the rise.

Emerging Drugs:

MesoPher
Durvalumab

Marketed Drugs:

Pemetrexed (Alimta®)
Cisplatin
Carboplatin
Gemcitabine (Gemzar®)
Vinorelbine

Key Companies:

Kissei Pharmaceutical Co., Ltd.
Novartis Pharmaceuticals
Oncovir, Inc.
Sumitomo Pharma Oncology
Bayer
Trizell Ltd
Hutchison Medipharma Limited
Targovax
Polaris Group
Epizyme, Inc.
Sanofi
AstraZeneca
Ascentage Pharma Group Inc.
Shionogi
Eli Lilly and Company
Incyte Corporation
GlaxoSmithKline

Market Segmentation:

By Type

Pleural Mesothelioma
Peritoneal Mesothelioma
Pericardial Mesothelioma
Testicular Mesothelioma
Others (including rare types)

By Administration Type

Oral Administration
Injectable Administration
- Subcutaneous
- Intravenous

What’s in It for You?

Gain insights into the evolving mesothelioma treatment landscape.
Understand the emerging drug pipeline and its potential impact on market dynamics.
Identify key players and their strategies for staying competitive in this niche oncology market.
Assess the commercial potential of new therapies and their adoption rates.
Discover the market trends and opportunities for investment and growth in the mesothelioma space.

Mesothelioma Market - Executive Summary
1. Introduction
2. Objectives
3. Key Findings
  1. Market Size 2025 & 2030: By Key Country (10MM)
  2. Global Market Size 2025 & 2030: By Key Segment
  3. Key Investments & Startup Analysis
4. Research Methodology
Understanding the Disease
1. Disease Overview
2. Classification
3. Signs and Symptoms
4. Risk Factors
5. Causes
6. Disease Biology & Digital Innovations
7. Stages & Staging System
8. Diagnostic Algorithm
9. Current Treatment Practices & Algorithm
10. Current Standard of Care and Treatment Gaps
11. Patient Demographics and Treatment Pathways
Guidelines
Unmet Needs
Epidemiology and Patient Population
1. Epidemiology Key Findings
2. Assumptions and Rationale: 10MM
3. Epidemiology Scenario: 10MM
4. U.S. Epidemiology Scenario
5. EU-5 Epidemiology
  1. U.K. Epidemiology Scenario
  2. Germany Epidemiology Scenario
  3. France Epidemiology Scenario
  4. Italy Epidemiology Scenario
  5. Spain Epidemiology Scenario
6. Japan Epidemiology Scenario
7. China Epidemiology Scenario
8. Australia Epidemiology Scenario
9. India Epidemiology Scenario
Real-world Data & Real-world Evidence
Drug Development Landscape
1. Existing Key Drug Candidate Profiles/ Marketed Therapies
2. Competitive Analysis and Differentiation
3. Overview of Similar/Competing Drugs in Clinical Trials
4. Future Trends and Emerging Drugs
Regulatory Strategy and Potential Challenges
1. Regulatory Pathways in Key Markets
2. Anticipated Regulatory Hurdles and Mitigation Strategies
3. Case Studies in Oncology Drug Regulation
4. Impact of Potential Changes to Regulatory Framework
Commercial Landscape
1. Market Size & Growth Rates
2. Key Approvals & Anticipated Loss of Exclusivity
3. PESTLE & Porter’s Five Forces Analysis
4. Market Shares, Positioning/Ranking
5. Market Drivers
6. Identification of Threats
7. Digital Evolution in Commercialization
Market Segmentation
Pricing, Reimbursement, and Access
1. Competitive Pricing Analysis
2. Reimbursement Landscape and Challenges
3. Strategies for Market Access and Equity
4. Patient Spending/Expenditure Analysis
Future Trends, Disruptions, and Opportunities
1. Analysis of Emerging Trends
2. Technological Impact
3. Impact of Potential Market Disruptors
4. Opportunities for Future Development and Expansion
5. Considerations for Investment Opportunities
Global Market Dynamics
1. Regional Regulatory Disparities
2. Cross-Border Partnership Strategies
3. Global Supply Chain Dynamics
4. Case Studies: Success and Failure in Global Markets
5. Strategies for Global Expansion and Localization
Company Profiles

Download Sample

Full Name *

Job Title *

Company *

Email *

Phone *

Country *

Message

↻

The field with (*) is required.

Choose License Type

Excel Data Pack

2500

Single User

4250

Multi User

5250

Corporate User

6900